Defects in the body’s regulatory T cells cause inflammation and autoimmune disease by altering the type of bacteria living in the gut, researchers from The University of Texas Health Science Center at Houston have discovered. The study, “Resetting microbiota by Lactobacillus reuteri inhibits T reg deficiency-induced autoimmunity via adenosine A2A receptors,” which will be published online December 19 in The Journal of Experimental Medicine, suggests that replacing the missing gut bacteria, or restoring a key metabolite called inosine, could help treat children with a rare and often fatal autoimmune disease called IPEX syndrome.
Category: Health
Prostate Cancer Therapeutics Industry Analysis And Forecasts to 2020
The prostate cancer drugs market is expected to nearly double by 2020, due to the introduction of new, more expensive drugs. PUNE, INDIA, December 19, 2016 / EINPresswire.com / — Global Prostate Cancer Therapeutics Market Global Prostate Cancer Therapeutics Industry Overview The prostate cancer drugs market is expected to nearly double by 2020, due to the introduction of new, more expensive drugs.
Oncolytics Biotech Inc. Announces 2016 Year-End Results
“Through this process, and with the help of our expanding senior team, we thoughtfully and deliberately put in place a plan that initially contemplates combinations with chemotherapy for late-stage clinical development, but will expand to include targeted immunotherapies over the longer term as we look to leverage the role of the immune system in patient treatment. In the coming months we will specifically define our first registration pathway.